RxDoctor Payments Data

Jose Febrillet

Physician Assistant · New York, NYNPI 1659502235

Payments from drug & device makers

$5,277in general payments, 2019–2025

Across 235 payments — averaging $22.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$912
  • AstraZeneca$855
  • AbbVie$755
  • Boehringer Ingelheim$525
  • Amgen$455
  • Amarin Pharma, Inc.$269
  • plus $2K from 22 others

What the payments were for

  • Food & beverage$5,277100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,277 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium456$275,085
JardianceEmpagliflozin134$108,950
MounjaroTirzepatide93$103,387
SynjardyEmpagliflozin/Metformin Hcl135$102,721
LinzessLinaclotide148$101,416
FarxigaDapagliflozin Propanediol111$84,277
EliquisApixaban96$75,144
TrulicityDulaglutide61$72,794
KerendiaFinerenone92$69,891
OzempicSemaglutide61$65,414
Tacrolimus126$59,186
Trelegy ElliptaFluticasone/Umeclidin/Vilanter76$53,228
DapagliflozinDapagliflozin Propanediol49$50,760
Xigduo XrDapaglifloz Propaned/Metformin62$50,710
Lidocaine283$50,659

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy, Synjardy Xr$525$230,264291 claims
Lilly USA, LLCMounjaro, Trulicity$148$176,181154 claims
AbbVieLinzess, Restasis, Creon$755$145,093198 claims
AstraZenecaFarxiga, Lokelma, Symbicort$855$104,652152 claims
PfizerEliquis$31$75,14496 claims
BayerKerendia$179$69,89192 claims
GSKTrelegy Ellipta, Anoro Ellipta$912$61,72892 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →